APA (7th ed.) Citation

Giaccone, G., Kim, C., Thompson, J., McGuire, C., Kallakury, B., Chahine, J. J., . . . McCutcheon, J. N. (2018). Pembrolizumab in patients with thymic carcinoma: A single-arm, single-centre, phase 2 study. Lancet Oncology, 19(3), 347. https://doi.org/10.1016/S1470-2045(18)30062-7

Chicago Style (17th ed.) Citation

Giaccone, Giuseppe, et al. "Pembrolizumab in Patients with Thymic Carcinoma: A Single-arm, Single-centre, Phase 2 Study." Lancet Oncology 19, no. 3 (2018): 347. https://doi.org/10.1016/S1470-2045(18)30062-7.

MLA (9th ed.) Citation

Giaccone, Giuseppe, et al. "Pembrolizumab in Patients with Thymic Carcinoma: A Single-arm, Single-centre, Phase 2 Study." Lancet Oncology, vol. 19, no. 3, 2018, p. 347, https://doi.org/10.1016/S1470-2045(18)30062-7.